3.6399
price up icon2.53%   0.0899
after-market アフターアワーズ: 3.68 0.0401 +1.10%
loading
前日終値:
$3.55
開ける:
$3.5711
24時間の取引高:
54,178
Relative Volume:
3.36
時価総額:
$9.21M
収益:
$556.00K
当期純損益:
$-5.28M
株価収益率:
-1.7009
EPS:
-2.14
ネットキャッシュフロー:
$-6.23M
1週間 パフォーマンス:
+8.33%
1か月 パフォーマンス:
+20.93%
6か月 パフォーマンス:
+10.64%
1年 パフォーマンス:
+7.69%
1日の値動き範囲:
Value
$3.55
$3.74
1週間の範囲:
Value
$2.945
$3.74
52週間の値動き範囲:
Value
$1.27
$9.4699

Cyclerion Therapeutics Inc Stock (CYCN) Company Profile

Name
名前
Cyclerion Therapeutics Inc
Name
セクター
Healthcare (1164)
Name
電話
617-621-7722
Name
住所
301 BINNEY STREET, CAMBRIDGE, MA
Name
職員
1
Name
Twitter
@Cyclerion
Name
次回の収益日
2024-12-15
Name
最新のSEC提出書
Name
CYCN's Discussions on Twitter

CYCN を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
CYCN
Cyclerion Therapeutics Inc
3.6399 9.21M 556.00K -5.28M -6.23M -2.14
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
468.85 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
314.94 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.24 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
250.30 28.51B 3.81B -644.79M -669.77M -6.24

Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2021-10-20 開始されました Truist Buy
2021-09-24 開始されました Cantor Fitzgerald Overweight
2019-06-03 開始されました Credit Suisse Neutral

Cyclerion Therapeutics Inc (CYCN) 最新ニュース

pulisher
Jun 18, 2025

Cyclerion Therapeutics Gains Shareholder Support at Annual Meeting - TipRanks

Jun 18, 2025
pulisher
May 31, 2025

Cyclerion Therapeutics (NASDAQ:CYCN) Trading 6.5% Higher – Time to Buy? - Defense World

May 31, 2025
pulisher
May 30, 2025

Regina Graul, Ph.D., Promoted to Chief Executive Officer - marketscreener.com

May 30, 2025
pulisher
May 09, 2025

Renaissance Technologies LLC Invests $34,000 in Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) - Defense World

May 09, 2025
pulisher
May 08, 2025

Cyclerion partners with Guggenheim for $20M stock sale By Investing.com - Investing.com Nigeria

May 08, 2025
pulisher
May 07, 2025

Cyclerion partners with Guggenheim for $20M stock sale - Investing.com Australia

May 07, 2025
pulisher
May 07, 2025

Cyclerion Therapeutics Enters $20M Sales Agreement - TipRanks

May 07, 2025
pulisher
May 06, 2025

CYCN: Company Stock Sale Proceeds Exclude Firm's Benefit | CYCN Stock News - GuruFocus

May 06, 2025
pulisher
Apr 21, 2025

Head to Head Survey: NewAmsterdam Pharma (NASDAQ:NAMS) vs. Cyclerion Therapeutics (NASDAQ:CYCN) - Defense World

Apr 21, 2025
pulisher
Mar 18, 2025

Dementia Market Expected to Experience Major Growth by 2032, According to DelveInsight | Charsire Biotech Corp, ProNeurogen Therapeutics, Resverlogix, Cyclerion Therapeutics, CSPC-NBP - Barchart

Mar 18, 2025
pulisher
Mar 13, 2025

Akebia Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 13, 2025
pulisher
Feb 16, 2025

Top Gainers Today: Reborn Coffee (REBN) Leads with a 65% Surge, Cyclerion (CYCN) and Signing Day Sports (SGN) Follow – market - HPBL

Feb 16, 2025
pulisher
Feb 05, 2025

3 US Penny Stocks With Market Caps Over $10M To Consider - Simply Wall St

Feb 05, 2025
pulisher
Feb 05, 2025

Cyclerion Therapeutics Inc (NASDAQ: CYCN) Is The Number One Stock Currently Moving. - Stocks Register

Feb 05, 2025
pulisher
Feb 05, 2025

Market Recap Check: Cyclerion Therapeutics Inc (CYCN)’s Negative Finish at 4.19, Up/Down -21.24 - The Dwinnex

Feb 05, 2025
pulisher
Feb 04, 2025

Small Cap Stocks To ConsiderFebruary 02nd - MarketBeat

Feb 04, 2025
pulisher
Feb 04, 2025

Cyclerion Therapeutics announces mixed shelf offering - MSN

Feb 04, 2025
pulisher
Feb 04, 2025

Cyclerion Therapeutics Inc’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - The InvestChronicle

Feb 04, 2025
pulisher
Feb 04, 2025

Check out these key findings about Cyclerion Therapeutics Inc (CYCN) - SETE News

Feb 04, 2025
pulisher
Feb 04, 2025

3 Penny Stocks to Watch Now, 2/4/25 - TipRanks

Feb 04, 2025
pulisher
Feb 03, 2025

A company insider recently sold 357,880 shares of Cyclerion Therapeutics Inc [CYCN]. Should You also Consider to Sale? – Knox Daily - Knox Daily

Feb 03, 2025
pulisher
Feb 03, 2025

Analyzing CYCN’s current quarter earnings projections - US Post News

Feb 03, 2025
pulisher
Feb 03, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

Feb 03, 2025
pulisher
Feb 03, 2025

Cyclerion’s Stock Surge: A Buying Opportunity? - timothysykes.com

Feb 03, 2025
pulisher
Feb 01, 2025

Stock summary: Cyclerion Therapeutics surged by 41.01% over the past five days - Business Upturn

Feb 01, 2025
pulisher
Jan 31, 2025

Stock market today: Signing Day Sports +62.89%, Cyclerion Therapeutics +57.43% among top gainers in early trading - Business Upturn

Jan 31, 2025
pulisher
Jan 31, 2025

Top Premarket Gainers -January 31, 2025 at 07:32 am EST - Marketscreener.com

Jan 31, 2025

Cyclerion Therapeutics Inc (CYCN) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$21.40
price down icon 2.10%
$35.84
price down icon 0.78%
$25.00
price down icon 3.40%
$98.18
price up icon 1.57%
$112.89
price down icon 0.90%
biotechnology ONC
$250.30
price down icon 1.22%
大文字化:     |  ボリューム (24 時間):